Agilent Technologies (NYSE: A) → Stocks, dividends, news, and other

Agilent Technologies

Free disabling of ads
Dividends News
Favorites

It is engaged in the production of measuring equipment, electronic medical equipment and equipment for chemical analysis. It also develops consumables and independently provides diagnostic services for the chemical composition of various food and medical products. For the state segment, food products are examined for the presence of various types of contamination (viruses, bacteria, chemicals, and microorganisms). In the energy industry, the company conducts research on biofuels as an alternative form of energy.

Environmental and criminal examination reveals the presence of metals, various biological additives and residues of medical drugs in athletes. Pharmaceutical diagnostics helps to create new medicines, check their purity and compliance with standards. Medical diagnostics mainly works in the field of Oncology, cardiovascular diseases, diabetes, but also allows you to quickly provide doctors with the necessary information on other diseases. Most of the company's product lines were developed by Hewlett-Packard.

  • A Symbol
  • NYSE Exchange
  • 14,800 Employees
7 rated
  • $104.83, $-0.78 (-0.74%) Previous Close
  • 893,965 Previous Volume
  • $61.13 / $107.62 52 week low / high
  • -1.87% Percent off 52 week high
  • 2020-10-21 Updated
  • 0.67% Dividend yield (trailing)
  • 0.68% Dividend yield (forward)
  • 306,744,094 Public float
  • 308,310,000 Outstanding shares
  • 46.92 P/E
  • 32.56 B Market Cap
Free disabling of ads

Financial statements

The information is not 100% up-to-date. There may be errors or something missing. Often something is missing, there are almost no errors, but I can't rule them out. Now I'm looking for a supplier of high-quality information, but so far what I find is expensive (about $ 2000 a year).
2015 2016 2017 2018 2019
Total Revenue 4B 4.2B 4.5B 4.9B 5.2B
Cost Of Revenue 2B 2B 2.1B 2.2B 2.4B
Gross Profit 2B 2.2B 2.4B 2.7B 2.8B
Research and Development 330M 330M 340M 390M 400M
Selling General and Admin 1.2B 1.1B 1.2B 1.4B 1.5B
Operating Expense 3.5B 3.5B 3.6B 4B 4.2B
Operating Income 550M 740M 840M 930M 930M
Other Income Expense Net -68M -190M -37M 15M -15M
EBIT 550M 740M 840M 930M 930M
Interest Income 66M 72M 79M 74M 73M
Pretax Income 480M 540M 800M 950M 920M
Income Tax 42M 82M 120M 630M -150M
Minority Interest 0 0 0 0 0
Net Income 400M 460M 680M 320M 1.1B
Net Income Basic 400M 460M 680M 320M 1.1B
2015 2016 2017 2018 2019
Current cash 2.2B 2.3B 2.7B 2.2B 1.4B
Short term investments
Receivables 610M 630M 720M 780M 930M
Inventory 540M 530M 580M 640M 680M
Other current assets 190M 99M 120M 130M 130M
Current assets 3.7B 3.6B 4.2B 3.8B 3.2B
Long term investments 86M 140M 140M 68M 110M
Property plant equipment 600M 640M 760M 820M 850M
Goodwill 2.4B 2.5B 2.6B 3B 3.6B
Intangible assets 450M 410M 360M 490M 1.1B
Other assets 92M 63M 140M 160M 190M
Total assets 7.5B 7.8B 8.4B 8.5B 9.5B
Accounts payable 280M 260M 310M 340M 350M
Current long term debt 620M
Other current liabilities 630M 640M 690M 760M 820M
Total current liabilities 980M 950M 1.3B 1.2B 2.1B
Long term debt 1.7B 1.9B 1.8B 1.8B 1.8B
Other liabilities 320M 270M 220M 930M 800M
Minority Interest 0 0 0 0 0
Total Liabilities 3.3B 3.6B 3.6B 4B 4.7B
Common stock 330M 320M 320M 320M 310M
Retained earning 5.6B 6.1B -130M -340M -18M
Treasury stock 1.4M 1.1M 1.1M 1.3M 1.5M
Capital surplus 9B 9.2B 5.3B 5.3B 5.3B
Shareholder equity 4.2B 4.2B 4.8B 4.6B 4.7B
Net tangible assets -1.7B -2B -1.6B -2.7B -4.5B
2015 2016 2017 2018 2019
Net Income 400M 460M 680M 320M 1.1B
Depreciation 250M 250M 210M 210M 240M
Changes in receivables -25M -93M -52M -150M
Changes in inventories -24M -7M -61M -83M -36M
Cash change -220M 41M 390M -430M -870M
Cash flow 490M 790M 890M 1.1B 1B
Capital expenditures -98M -140M -180M -180M -160M
Investments -1M -82M -1M -11M -23M
Investing activity other -240M -1M -1M -2M -3M
Total investing cash flows 410M -480M -300M -710M -1.6B
Dividends paid -130M -150M -170M -190M -210M
Net borrowings 260M 110M -210M 600M
Other financing cash flows -730M -6M -14M
Cash flow financing -1.1B -270M -200M -800M -300M
Exchange rate effect -48M -1M 7M -17M 2M
Free disabling of ads
Free disabling of ads